TransMedics Group, Inc.

TransMedics Group, Inc.verified

TMDX

Price:

$151.03

Market Cap:

$5.04B

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of...[Read more]

Industry

Medical - Devices

IPO Date

2019-05-02

Stock Exchange

NASDAQ

Ticker

TMDX

The ROE as of September 2024 (TTM) for TransMedics Group, Inc. (TMDX) is 1.96%

According to TransMedics Group, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.96%. This represents a change of -353.00% compared to the average of -0.77% of the last 4 quarters.

TransMedics Group, Inc. (TMDX) Historical ROE (quarterly & annually)

How has TMDX ROE performed in the past?

The mean historical ROE of TransMedics Group, Inc. over the last ten years is 31.36%. The current 1.96% ROE has changed -93.76% with respect to the historical average. Over the past ten years (40 quarters), TMDX's ROE was at its highest in in the December 2018 quarter at 158.24%. The ROE was at its lowest in in the September 2018 quarter at -196.50%.

Quarterly (TTM)
Annual

Average

31.36%

Median

-23.50%

Minimum

-65.16%

Maximum

492.35%

TransMedics Group, Inc. (TMDX) ROE by Quarter and Year

Discovering the peaks and valleys of TransMedics Group, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.89%

Maximum Annual ROE = 492.35%

Minimum Annual Increase = -119.89%

Minimum Annual ROE = -65.16%

Quarterly (TTM)
Annual
YearROEChange
2023-18.24%-5.66%
2022-19.34%-70.33%
2021-65.16%135.49%
2020-27.67%-54.92%
2019-61.39%-112.47%
2018492.35%3.89%
201712.34%-119.89%

TransMedics Group, Inc. (TMDX) Average ROE

How has TMDX ROE performed in the past?

The current ROE of TransMedics Group, Inc. (TMDX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-34.25%

5-year avg

-38.36%

10-year avg

31.36%

TransMedics Group, Inc. (TMDX) ROE vs. Peers

How is TMDX’s ROE compared to its peers?

TransMedics Group, Inc.’s ROE is less than Inspire Medical Systems, Inc. (1.03%), greater than Inari Medical, Inc. (-12.76%), less than InMode Ltd. (19.39%), less than Insulet Corporation (50.53%), less than Silk Road Medical, Inc (0%), greater than Pulmonx Corporation (-37.30%), greater than Orthofix Medical Inc. (-50.79%), greater than TELA Bio, Inc. (-20.68%), greater than CVRx, Inc. (-252.57%), greater than NeuroPace, Inc. (-77.62%), greater than Delcath Systems, Inc. (-195.26%), greater than ShockWave Medical, Inc. (-379.90%), less than Penumbra, Inc. (24.79%), less than Masimo Corporation (1.22%), less than null (5.91%),

Build a custom stock screener for TransMedics Group, Inc. (TMDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TransMedics Group, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TransMedics Group, Inc. (TMDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TransMedics Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is TransMedics Group, Inc.'s ROE?

How is the ROE calculated for TransMedics Group, Inc. (TMDX)?

What is the highest ROE for TransMedics Group, Inc. (TMDX)?

What is the 3-year average ROE for TransMedics Group, Inc. (TMDX)?

What is the 5-year average ROE for TransMedics Group, Inc. (TMDX)?

How does the current ROE for TransMedics Group, Inc. (TMDX) compare to its historical average?